3-Hydroxy-19-nor-17α-pregna-1,3,5(10)-triene-21,17β-carbolactone as inhibitor of 17β-hydroxysteroid dehydrogenase type 2

Add time:08/09/2019    Source:sciencedirect.com

Introducing a spiro-γ-lactone at position 17 of an estradiol nucleus provokes a potent inhibition of 17β-hydroxysteroid dehydrogenase (17β-HSD) type 2. Synthesis of such a compound, namely 6 (3-hydroxy-19-nor-17α-pregna-1,3,5(10)-triene-21,17β-carbolactone), was performed in five steps, starting with estrone. Inhibition analysis of this compound, the first inhibitor of 17β-HSD, using human placental microsomes and 4-androstene-3,17-dione as substrate shows a Ki value of 0.25 μM.

We also recommend Trading Suppliers and Manufacturers of 3-hydroxy-19-nor-1,3,5(10)-cholatrien-24-oic acid (cas 100772-18-7). Pls Click Website Link as below: cas 100772-18-7 suppliers

Prev:Synthesis of (2R, 3S)-methyl-2-fluoro-3-(n-benzoylamino)-3-phenylpropanoate: Modified side chain of taxol
Next:The importance of corticosterone in mediating restraint-induced weight loss in rats)